Global Intravenous Iron Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
The report focuses on the Intravenous Iron Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Intravenous Iron Drugs market.
Major Players in the Intravenous Iron Drugs market are:
Daiichi Sankyo Company, Ltd.
Sanofi
Shield Therapeutics Plc.
AMAG Pharmaceuticals
Pharmacosmos A/S
Vifor Pharma Management Ltd.
AbbVie, Inc.
On the basis of types, the Intravenous Iron Drugs market is primarily split into:
Iron Dextran
Iron Sucrose
Ferric Carboxymaltose
Ferric Gluconate
On the basis of applications, the market covers:
Chronic Kidney Disease
Inflammatory Bowel Disease
Cancer
Other Diseases
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
- 1 Intravenous Iron Drugs Market Overview
- 1.1 Product Overview and Scope of Intravenous Iron Drugs Market
- 1.2 Intravenous Iron Drugs Market Segment by Type
- 1.2.1 Global Intravenous Iron Drugs Market Sales and CAGR (%) Comparison by Type (2017-2029)
- 1.3 Global Intravenous Iron Drugs Market Segment by Application
- 1.3.1 Intravenous Iron Drugs Market Consumption (Sales) Comparison by Application (2017-2029)
- 1.4 Global Intravenous Iron Drugs Market, Region Wise (2017-2029)
- 1.5 Global Market Size (Revenue) of Intravenous Iron Drugs (2017-2029)
- 1.5.1 Global Intravenous Iron Drugs Market Revenue Status and Outlook (2017-2029)
- 1.5.2 Global Intravenous Iron Drugs Market Sales Status and Outlook (2017-2029)
- 1.6 Influence of Regional Conflicts on the Intravenous Iron Drugs Industry
- 1.7 Impact of Carbon Neutrality on the Intravenous Iron Drugs Industry
- 2 Intravenous Iron Drugs Market Upstream and Downstream Analysis
- 2.1 Intravenous Iron Drugs Industrial Chain Analysis
- 2.2 Key Raw Materials Suppliers and Price Analysis
- 2.3 Key Raw Materials Supply and Demand Analysis
- 2.4 Market Concentration Rate of Raw Materials
- 2.5 Manufacturing Process Analysis
- 2.6 Manufacturing Cost Structure Analysis
- 2.6.1 Labor Cost Analysis
- 2.6.2 Energy Costs Analysis
- 2.6.3 R&D Costs Analysis
- 2.7 Major Downstream Buyers of Intravenous Iron Drugs Analysis
- 2.8 Impact of COVID-19 on the Industry Upstream and Downstream
- 3 Players Profiles
- 3.1 Daiichi Sankyo Company, Ltd.
- 3.1.1 Daiichi Sankyo Company, Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.1.2 Product Profiles, Application and Specification
- 3.1.3 Intravenous Iron Drugs Market Performance (2017-2022)
- 3.1.4 Business Overview
- 3.2 Sanofi
- 3.2.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.2.2 Product Profiles, Application and Specification
- 3.2.3 Intravenous Iron Drugs Market Performance (2017-2022)
- 3.2.4 Business Overview
- 3.3 Shield Therapeutics Plc.
- 3.3.1 Shield Therapeutics Plc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.3.2 Product Profiles, Application and Specification
- 3.3.3 Intravenous Iron Drugs Market Performance (2017-2022)
- 3.3.4 Business Overview
- 3.4 AMAG Pharmaceuticals
- 3.4.1 AMAG Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.4.2 Product Profiles, Application and Specification
- 3.4.3 Intravenous Iron Drugs Market Performance (2017-2022)
- 3.4.4 Business Overview
- 3.5 Pharmacosmos A/S
- 3.5.1 Pharmacosmos A/S Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.5.2 Product Profiles, Application and Specification
- 3.5.3 Intravenous Iron Drugs Market Performance (2017-2022)
- 3.5.4 Business Overview
- 3.6 Vifor Pharma Management Ltd.
- 3.6.1 Vifor Pharma Management Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.6.2 Product Profiles, Application and Specification
- 3.6.3 Intravenous Iron Drugs Market Performance (2017-2022)
- 3.6.4 Business Overview
- 3.7 AbbVie, Inc.
- 3.7.1 AbbVie, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
- 3.7.2 Product Profiles, Application and Specification
- 3.7.3 Intravenous Iron Drugs Market Performance (2017-2022)
- 3.7.4 Business Overview
- 4 Global Intravenous Iron Drugs Market Landscape by Player
- 4.1 Global Intravenous Iron Drugs Sales and Share by Player (2017-2022)
- 4.2 Global Intravenous Iron Drugs Revenue and Market Share by Player (2017-2022)
- 4.3 Global Intravenous Iron Drugs Average Price by Player (2017-2022)
- 4.4 Global Intravenous Iron Drugs Gross Margin by Player (2017-2022)
- 4.5 Intravenous Iron Drugs Market Competitive Situation and Trends
- 4.5.1 Intravenous Iron Drugs Market Concentration Rate
- 4.5.2 Intravenous Iron Drugs Market Share of Top 3 and Top 6 Players
- 4.5.3 Mergers & Acquisitions, Expansion
- 5 Global Intravenous Iron Drugs Sales, Revenue, Price Trend by Type
- 5.1 Global Intravenous Iron Drugs Sales and Market Share by Type (2017-2022)
- 5.2 Global Intravenous Iron Drugs Revenue and Market Share by Type (2017-2022)
- 5.3 Global Intravenous Iron Drugs Price by Type (2017-2022)
- 5.4 Global Intravenous Iron Drugs Sales, Revenue and Growth Rate by Type (2017-2022)
- 5.4.1 Global Intravenous Iron Drugs Sales, Revenue and Growth Rate of Iron Dextran (2017-2022)
- 5.4.2 Global Intravenous Iron Drugs Sales, Revenue and Growth Rate of Iron Sucrose (2017-2022)
- 5.4.3 Global Intravenous Iron Drugs Sales, Revenue and Growth Rate of Ferric Carboxymaltose (2017-2022)
- 5.4.4 Global Intravenous Iron Drugs Sales, Revenue and Growth Rate of Ferric Gluconate (2017-2022)
- 6 Global Intravenous Iron Drugs Market Analysis by Application
- 6.1 Global Intravenous Iron Drugs Consumption and Market Share by Application (2017-2022)
- 6.2 Global Intravenous Iron Drugs Consumption Revenue and Market Share by Application (2017-2022)
- 6.3 Global Intravenous Iron Drugs Consumption and Growth Rate by Application (2017-2022)
- 6.3.1 Global Intravenous Iron Drugs Consumption and Growth Rate of Chronic Kidney Disease (2017-2022)
- 6.3.2 Global Intravenous Iron Drugs Consumption and Growth Rate of Inflammatory Bowel Disease (2017-2022)
- 6.3.3 Global Intravenous Iron Drugs Consumption and Growth Rate of Cancer (2017-2022)
- 6.3.4 Global Intravenous Iron Drugs Consumption and Growth Rate of Other Diseases (2017-2022)
- 7 Global Intravenous Iron Drugs Sales and Revenue Region Wise (2017-2022)
- 7.1 Global Intravenous Iron Drugs Sales and Market Share, Region Wise (2017-2022)
- 7.2 Global Intravenous Iron Drugs Revenue and Market Share, Region Wise (2017-2022)
- 7.3 Global Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.4 United States Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.5 Europe Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.6 China Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.7 Japan Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.8 India Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.9 Southeast Asia Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.10 Latin America Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 7.11 Middle East and Africa Intravenous Iron Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
- 8 Global Intravenous Iron Drugs Market Forecast (2022-2029)
- 8.1 Global Intravenous Iron Drugs Sales, Revenue Forecast (2022-2029)
- 8.1.1 Global Intravenous Iron Drugs Sales and Growth Rate Forecast (2022-2029)
- 8.1.2 Global Intravenous Iron Drugs Revenue and Growth Rate Forecast (2022-2029)
- 8.1.3 Global Intravenous Iron Drugs Price and Trend Forecast (2022-2029)
- 8.2 Global Intravenous Iron Drugs Sales and Revenue Forecast, Region Wise (2022-2029)
- 8.2.1 United States Intravenous Iron Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.2 Europe Intravenous Iron Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.3 China Intravenous Iron Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.4 Japan Intravenous Iron Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.5 India Intravenous Iron Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.6 Southeast Asia Intravenous Iron Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.7 Latin America Intravenous Iron Drugs Sales and Revenue Forecast (2022-2029)
- 8.2.8 Middle East and Africa Intravenous Iron Drugs Sales and Revenue Forecast (2022-2029)
- 8.3 Global Intravenous Iron Drugs Sales, Revenue and Price Forecast by Type (2022-2029)
- 8.3.1 Global Intravenous Iron Drugs Revenue and Growth Rate of Iron Dextran (2022-2029)
- 8.3.2 Global Intravenous Iron Drugs Revenue and Growth Rate of Iron Sucrose (2022-2029)
- 8.3.3 Global Intravenous Iron Drugs Revenue and Growth Rate of Ferric Carboxymaltose (2022-2029)
- 8.3.4 Global Intravenous Iron Drugs Revenue and Growth Rate of Ferric Gluconate (2022-2029)
- 8.4 Global Intravenous Iron Drugs Consumption Forecast by Application (2022-2029)
- 8.4.1 Global Intravenous Iron Drugs Consumption Value and Growth Rate of Chronic Kidney Disease (2022-2029)
- 8.4.2 Global Intravenous Iron Drugs Consumption Value and Growth Rate of Inflammatory Bowel Disease (2022-2029)
- 8.4.3 Global Intravenous Iron Drugs Consumption Value and Growth Rate of Cancer (2022-2029)
- 8.4.4 Global Intravenous Iron Drugs Consumption Value and Growth Rate of Other Diseases (2022-2029)
- 8.5 Intravenous Iron Drugs Market Forecast Under COVID-19
- 9 Industry Outlook
- 9.1 Intravenous Iron Drugs Market Drivers Analysis
- 9.2 Intravenous Iron Drugs Market Restraints and Challenges
- 9.3 Intravenous Iron Drugs Market Opportunities Analysis
- 9.4 Emerging Market Trends
- 9.5 Intravenous Iron Drugs Industry Technology Status and Trends
- 9.6 News of Product Release
- 9.7 Consumer Preference Analysis
- 9.8 Intravenous Iron Drugs Industry Development Trends under COVID-19 Outbreak
- 9.8.1 Global COVID-19 Status Overview
- 9.8.2 Influence of COVID-19 Outbreak on Intravenous Iron Drugs Industry Development
- 10 Research Findings and Conclusion
- 11 Appendix
- 11.1 Methodology
- 11.2 Research Data Source
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook